Table 1 Clinical characteristics of the patient cohort

From: Interleukin-10-regulated tumour tolerance in non-small cell lung cancer

Sample ID

Histolo-gical classi-fication

Maximal tumour diameter (cm)

Grading

T

N

M

TNM stadium

Gender

Age

Average smoking (P/Y)

1-MP

SCC

1.3

G3

1b

0

0

IA

Male

80

40

2-MP

SCC

5.1

G3

1a

0

0

IA

Male

57

40

3-MP

ADC

5

G3

2a

0

0

IB

Male

79

60

4-MP

SCC

2

G3

1b

1

0

IIA

Female

53

25

5-MP

SCC

10.5

G2

3

0

0

IIB

Female

67

50

8-MP

SCC

5.5

G3

3

0

0

IIB

Male

66

30

9-MP

ADC

2.7

G2

1b

2

0

IIIA

Female

84

0

13-MP

SCC

3

G3

1b

0

0

IA

Male

69

50

14-MP

SCC

1.9

G2

1a

0

0

IA

Female

58

30

15-MP

ADC

2,5

G3

1b

0

0

IA

Male

63

100

16-MP

ADC

4.6

G3

3

0

0

II B

Female

70

15

17-MP

ADC

2.6

G2

2

0

0

IB

Male

74

70

19-MP

ADC

6.5

#

2b

0

0

IIA

Female

55

30

20-MP

ADC

2.8

G3

1b

0

0

IA

Male

65

60

21-MP

SCC

2.5

G1

1b

0

0

IA

Male

41

10

22-MP

ADC

7

G3

2b

1

0

IIB

Male

68

82

23-MP

ADC

4.5

G2

2a

0

0

IB

Male

73

75

26-MP

ADC

1.3

G3

1a

0

1

IV

Female

52

50

27-MP

ADC

1.4

G3

1a

0

0

IA

Female

70

50

28-MP

ADC

1.2

G3

1a

0

0

IA

Male

76

60

29-MP

SCC

3.7

G3

1b

0

0

IIB

Male

74

100

30-MP

SCC

1.8

G3

1a

0

0

IA

Female

70

30

32-MP

ADC

4.4

G3

2a

2

0

IIIA

Female

60

30

34-MP

ADC

1.8

G3

1

0

0

I A

Female

51

45

35-MP

ADC

3

G3

1b

0

0

IA

Female

72

0

36-MP

SCC

3.5

G3

2a

1

0

IB

Male

74

40

37-MP

SCC

3.3

G2

2a

1

0

IIA

Male

60

45

39-MP

ADC

6

G3

2b

0

0

IIA

Male

65

42

40-MP

ADC

1.8

G3

1a

1

0

IIA

Male

82

100

41-MP

SCC

1.3

G3

3

1

0

IIIA

Male

70

42

42-MP

SCC

1.5

G3

2b

1

0

IIB

Male

74

40

46-MP

SCC

9.5

G3

3

1

0

IIIA

Male

60

30

47-MP

SCC

6

G3

2b

0

0

IIA

Male

64

80

48-MP

SCC

5

G2

2b

0

0

IIA

Male

55

20

  1. Abbreviations: ADC=adenocarcinoma; SCC=squamous cell carcinoma of the lung.
  2. T-primary tumour: 0=no evidence of primary tumour; 1a=tumour 2 cm or less in greatest dimension; 1b=tumour more than 2 cm but not more than 3 cm in greatest dimension; 2a=tumour more than 3 cm but not more than 5 cm in greatest dimension; 2b=tumour more than 5 cm but not more than 7 cm in greatest dimension; 3=tumour more than 7 cm.
  3. N-regional lymph nodes: 0=no regional lymph node metastasis; 1=metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes and intrapulmonary nodes, including involvement by direct extension; 2=Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s).
  4. M-distant metastasis: 0=no distant metastasis; 1=distant metastasis.
  5. Histopathological grading: G1=well differentiated; G2=moderately differentiated; G3=poorly differentiated.
  6. #No information available.